is retatrutide a triple agonist ly3437943 glp-1 gip glucagon mechanism Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based What Is Retatrutide? Complete Research

Tip 2: Hydrate with Electrolytes Staying hydrated is important when using GLP-1 medications, but what you drink matters too

With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures

Retatrutide does both

Make meals smaller but don't skip them entirely

[10] Current evidence suggests that the risk of vision problems with GLP-1 medications appears primarily related to rapid glycaemic improvement in patients with pre-existing retinopathy rather than a direct medication effect across all patients